The long-term prognosis in untreated cerebral aneurysms: I. The incidence of late hemorrhage in cerebral aneurysm: a 10-year evaluation of 364 patients

Annals of Neurology
H R WinnJ A Jane

Abstract

Three hundred sixty-four patients who suffered a subarachnoid hemorrhage from an aneurysm in either the posterior communicating or anterior communicating artery and who were not surgically treated have been followed for up to 21 years in order to determine the frequency of subsequent hemorrhage. For patients surviving six months: (1) rebleeding occurs on the average of 3.5% per year during the first decade; (2) the mortality associated with a late rebleed is 67%; (3) high blood pressure and female sex predispose to late rebleeding in posterior communicating artery aneurysms; (4) young patients take longer to rebleed than older patients but do so at the same rate; and (5) increase in aneurysm size as judged by routine arteriography six months after the initial hemorrhage did not correlate with rebleeding, although an increase in size had occurred in all patients who were studied angiographically at the time of their late rebleed.

References

Feb 1, 1966·Archives of Neurology·A E RichardsonD Yashon
Jan 1, 1971·Acta Neurologica Scandinavica·H Troupp
Feb 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·V LogueW L Nixon
Jan 1, 1967·Acta Neurologica Scandinavica·J H Trumpy
Mar 1, 1956·Journal of Neurosurgery·R H DUNSMORE, J L POLCYN
Jul 1, 1962·Journal of Neurosurgery· af BJORKESTEN, H TROUPP
Jun 23, 1951·Journal of the American Medical Association·L A MOUNT
Jan 1, 1950·Archives of Neurology and Psychiatry·H H HYLAND
Jan 1, 1950·Acta Medica Scandinavica·E ASK-UPMARK, D INGVAR
Feb 21, 1948·Journal of the American Medical Association·W B HAMBY
Apr 1, 1964·Journal of Neurosurgery·A E RICHARDSONP M PAYNE

❮ Previous
Next ❯

Citations

Apr 1, 1978·Annals of Neurology·R Karis
Jan 1, 1991·Acta neurochirurgica·T Inagawa
Jan 1, 1989·Acta neurochirurgica·P A GómezJ M Cañizal
Mar 22, 2008·Journal of Neurology·José M FerroR Peralta
Mar 2, 2006·Pituitary·Ilonka Kreitschmann-Andermahr
Oct 30, 2008·Current Neurology and Neuroscience Reports·Joshua M Levine
Feb 13, 2009·Current Treatment Options in Neurology·Joshua M Levine
Jan 1, 1983·Clinical Neurology and Neurosurgery·L E Velghe, P De Wit
Jan 1, 1997·International Journal of Technology Assessment in Health Care·A I MushlinC E Phelps
Aug 9, 2001·Journal of Clinical Pharmacy and Therapeutics·P K SarkarS Ballantyne
Jul 20, 1978·The New England Journal of Medicine·T M Sundt, J P Whisnant
Mar 19, 1981·The New England Journal of Medicine·R G Ojemann
Apr 28, 1983·The New England Journal of Medicine·A S LeveyJ P Kassirer
Jun 14, 2003·The Neurologist·Eva H Brilstra, Gabriel J E Rinkel
Dec 31, 2008·Critical Care Medicine·Michael N Diringer
Oct 1, 1992·Acta Neurologica Scandinavica·D W DippelJ D Habbema
Sep 29, 1990·BMJ : British Medical Journal·J D PickardJ S Garfield
Sep 1, 1977·Journal of Neurology, Neurosurgery, and Psychiatry·R D Hayward
Jan 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·P M CrawfordM D Shaw
Feb 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·T D HawkinsR Hanka
Dec 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·J V ByrneS A Renowden
Jun 1, 1978·Journal of Neurosurgery
Jun 1, 1978·Journal of Neurosurgery·J T McFadden
May 1, 1981·Journal of Neurosurgery·R A RoskiF E Nulsen
Mar 1, 1985·Journal of Neurosurgery·J A JaneH R Winn
Sep 1, 1985·Journal of Neurosurgery·J Brismar, G Sundbärg
Nov 1, 1993·Journal of Neurosurgery·J J Jafar, H L Weiner
Mar 1, 1994·Journal of Neurosurgery·R A SolomonJ Pile-Spellman
Jan 25, 2002·Journal of Neurosurgery·Rod J Oskouian, J Patrick Johnson
Aug 2, 2008·Journal of Neurosurgery·Gavin Britz, H Richard Winn
Feb 2, 2013·Surgical Neurology International·Abdolkarim RahmanianJuha Hernesniemi
Jan 1, 1995·Acta neurochirurgica·F van CalenberghC Plets
Oct 1, 1996·The British Journal of Radiology·J Byrne
Jan 1, 1995·Acta neurochirurgica·H KamitaniY Tokuyama
Jan 1, 1996·Acta neurochirurgica·Y OrzS Kobayashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.